Literature DB >> 12624661

Differential diagnosis of prostate lesions with the use of biomagnetic measurements and non-linear analysis.

P Anninos1, I Papadopoulos, A Kotini, A Adamopoulos.   

Abstract

The purpose of this study was to investigate the biomagnetic activity emitted from the prostate gland and to differentiate cancerous from benign prostate lesions with the use of biomagnetic measurement and non-linear analysis. Magnetic recordings were obtained from 47 patients with palpable prostate lesions. Histology revealed 24 prostate cancer patients and 23 benign prostate hyperplasia (BPH) patients. The superconducting quantum interference device (SQUID) biomagnetometer was used to measure the prostate's magnetic field by placing the SQUID detector 3 mm above the symphysis pubis. The magnetic field recorded in the 2-7 Hz frequency range was of high amplitude in most malignant lesions whereas all benign cases were of low amplitude. According to our results, the sensitivity, specificity, positive predictive value and negative predictive value were 83.33%, 100%, 100% and 85.18%, respectively. By applying the Grassberger-Procaccia algorithm to the magnetoprostatogram time series in malignant and benign prostate lesions we found clear saturation in malignant prostate lesions with m>7 whereas in the benign lesions there was not clear saturation. Prostate cancer emits higher biomagnetic activity than the BPH. This confirms a higher angiogenic activity in prostate cancer than the BPH lesions. Furthermore, the saturation value in the estimation of the correlation dimension of the attractor for the cancer lesions confirms the lower complexity of the system in comparison to the BPH, which is characterized by higher complexity.

Entities:  

Mesh:

Year:  2003        PMID: 12624661     DOI: 10.1007/s00240-003-0297-2

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  11 in total

1.  [Model of screening for prostatic cancer among patients with prostate specific antigen concentration of 4-10 ng/ml in blood].

Authors:  G G Karazanashvili; L G Managadze
Journal:  Urologiia       Date:  2000 Nov-Dec

2.  Fetal magnetoencephalographic mapping in normal and pre-eclamptic pregnancies.

Authors:  P Anastasiadis; P Anninos; P Diamantopoulos; E Sivridis
Journal:  J Obstet Gynaecol       Date:  1997-03       Impact factor: 1.246

3.  The hemodynamics of the umbilical artery in normal and pre-eclamptic pregnancies. A new application of SQUID biomagnetometry.

Authors:  P Anastasiadis; P Anninos; A Adamopoulos; E Sivridis
Journal:  J Perinat Med       Date:  1997       Impact factor: 1.901

4.  Comparison of perspectives on prostate cancer: analyses of survey data.

Authors:  E D Crawford; C L Bennett; N N Stone; S J Knight; E DeAntoni; L Sharp; M B Garnick; H A Porterfield
Journal:  Urology       Date:  1997-09       Impact factor: 2.649

5.  The fetal magnetocardiogram.

Authors:  V Kariniemi; J Ahopelto; P J Karp; T E Katila
Journal:  J Perinat Med       Date:  1974       Impact factor: 1.901

Review 6.  Magnetoencephalography and epilepsy research.

Authors:  D F Rose; P D Smith; S Sato
Journal:  Science       Date:  1987-10-16       Impact factor: 47.728

7.  Antenatal fetal magnetocardiography: a new method for fetal surveillance?

Authors:  A Quinn; A Weir; U Shahani; R Bain; P Maas; G Donaldson
Journal:  Br J Obstet Gynaecol       Date:  1994-10

8.  Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.

Authors:  H J Luboldt; A Bex; A Swoboda; J Hüsing; H Rübben
Journal:  Eur Urol       Date:  2001-02       Impact factor: 20.096

9.  The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy.

Authors:  R J Babaian; D A Johnston; W Naccarato; A Ayala; V A Bhadkamkar; H A Fritsche HA
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

10.  Biomagnetic measurements using squids.

Authors:  P A Anninos; G Anogianakis; K Lehnertz; C Pantev; M Hoke
Journal:  Int J Neurosci       Date:  1987-12       Impact factor: 2.292

View more
  2 in total

1.  Effects of pulsed electromagnetic fields on benign prostate hyperplasia.

Authors:  Xenophon K Giannakopoulos; Christos Giotis; Spyridon Ch Karkabounas; Ioannis I Verginadis; Yannis V Simos; Dimitrios Peschos; Angelos M Evangelou
Journal:  Int Urol Nephrol       Date:  2011-05-03       Impact factor: 2.370

2.  Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia.

Authors:  Hany M Elgohary; Sayed A Tantawy
Journal:  J Phys Ther Sci       Date:  2017-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.